Navigation Links
Boston Scientific Announces Results for First Quarter Ended March 31, 2011
Date:4/20/2011

NATICK, Mass., April 20, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2011, as well as net sales and earnings per share (EPS) guidance for the second quarter and updated guidance for the full year 2011. The Company exceeded its adjusted EPS guidance range for the quarter and raised adjusted EPS guidance for the full year 2011. First quarter GAAP results included a previously anticipated gain recognized on the sale of the Neurovascular business of $759 million pre-tax ($530 million after-tax), net of separation costs. In addition, primarily due to a reduction in the estimated size of the U.S. Cardiac Rhythm Management (CRM) market, which led to lower projected U.S. CRM results compared to prior forecasts, the Company also recorded a $723 million (pre- and after-tax) estimated goodwill impairment charge associated with its U.S. CRM business unit during the quarter. As a result, GAAP EPS for the first quarter of 2011 was below previous guidance, and the Company's updated full year GAAP EPS guidance reflects this charge. The amount of the goodwill impairment charge is subject to finalization and is estimated to range between $650 million and $800 million.

First quarter highlights:

  • Achieved sales of $1.925 billion, at the high end of the Company's previous guidance range, and adjusted EPS of $0.22, exceeding previous guidance; reported GAAP earnings of $0.01 per share, lower than previous guidance due primarily to the impact of a $0.47 per share goodwill impairment charge.
  • Maintained leadership position in the drug-eluting stent market with a worldwide share of 36 percent and U.S. share of 46 percent (each excluding a negative one-share point impact of product transition reserves), and continued to grow PROMUS Element™ sales, with a European market share of more
    '/>"/>

  • SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related medicine technology :

    1. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
    2. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
    3. Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data
    4. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
    5. Boston Scientific Announces Its ACC 2011 Schedule
    6. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
    7. Boston Scientific to Webcast Analyst Event
    8. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
    9. Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System
    10. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
    11. Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Tobramycin Market, ... is a traditional antibiotic whose eye drop and ointment ... of potential infection or inflammation caused by eye infection. ... are able to produce tobramycin, among which the ...
    (Date:8/28/2015)... Research and Markets ... the "Investigation Report on China,s Quetiapine Market, ... Developed by AstraZeneca plc, quetiapine (under the trade ... the treatment of schizophrenia. Approved by CFDA to ... the Catalogue of Drugs for the Basic National ...
    (Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... Novartis, ranibizumab was approved by CFDA to treat wet ... Lucentis, a product of Novartis, is available in the ... self- developed drug for the treatment of wet AMD ...
    Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2
    (Date:8/28/2015)... ... August 28, 2015 , ... Joining a ... Memorial Hospital recently transitioned management companies to partner with Wound Care Advantage (WCA) ... outpatient wound center. , Transitioning wound care management providers can be a ...
    (Date:8/28/2015)... ... , ... With the goal of furthering music education programs in schools, the ... County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best ... the underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best ...
    (Date:8/28/2015)... Michigan (PRWEB) , ... August 28, 2015 , ... On ... Western Michigan, joined as sponsor of the “Music With A Mission” benefit concert in ... behind the event was to raise money to support music education programs in the ...
    (Date:8/28/2015)... ... 28, 2015 , ... Drugs and alcohol abuse by employees ... new approach on solutions in his new book ":Unraveling The Psychological Mystery of ... together for meaningful group meetings. "This would educate the employees on not ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... loyalty at a low cost. Personalized with practice contact information and logos, Calendars ... Dental offices can also incorporate Calendars into seasonal mailings, thank you and welcome ...
    Breaking Medicine News(10 mins):Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2
    ... ... to showcase her work at the 32nd annual Artexpo New York. Renea’s sculpted ... movement of the imagination in a textured oasis. Art enthusiasts say her use ... real a vivid, truly amazing work. Each of the swirls she creates ...
    ... ... ... , ... , , , , ...
    ... New ... men, as well as infertility diagnosis, treatment and options. , ... (PRWEB) March 9, 2010 -- A new Australian website ( ... attempts at conceiving aren,t successful within the first few months. , , ,The reality is ...
    ... ... ... ... , , ...
    ... ... ... ... ...
    ... ... ... , ... , , ...
    Cached Medicine News:Health News:Red Hot Artist Renea Menzies Has Flower Power; Houston, Texas Artist Renea Menzies Showcases Her Work in NY 2Health News:Red Hot Artist Renea Menzies Has Flower Power; Houston, Texas Artist Renea Menzies Showcases Her Work in NY 3Health News:Justice Department Files for Immediate Relief Regarding Conditions at Conway Human Development Center, in Conway, Arkansas 2Health News:Justice Department Files for Immediate Relief Regarding Conditions at Conway Human Development Center, in Conway, Arkansas 3Health News:Justice Department Files for Immediate Relief Regarding Conditions at Conway Human Development Center, in Conway, Arkansas 4Health News:'Get Pregnant' Aims To Help Couples Conceive Naturally, Faster 2Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 2Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 3Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 4Health News:MedCAREERS GROUP, Inc. Assumes Operating Control of WorkAbroad.com 5Health News:IntraHealth International Opens Washington, D.C. Office 2Health News:IntraHealth International Opens Washington, D.C. Office 3Health News:IntraHealth International Opens Washington, D.C. Office 4Health News:IntraHealth International Opens Washington, D.C. Office 5Health News:South Dakota Students with Asthma Can Breathe Easier After New Law Allows Self-Administered Medications 2
    ... Compact high speed refrigerated floor-standing centrifuge. ... popular protocols of classical 3 liter ... programmed radius including for adaptors, informative ... acceleration & 10 braking rates (100 ...
    ... The Rotanta 460 ... an extraordinary line that ... of demands. They feature ... performance. Their state-of-the-art technology ...
    ... Spinchron 15 centrifuge provides all ... needed for today's full-service clinical ... has a speed up to ... to spin tubes, plates and ...
    ... an uniquely designed direct reading ... which tubes are filled, transported ... carrying tray. Spin cycle of ... operation, automatic electric brake, high ...
    Medicine Products: